Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Operating Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Operating Profit (Excl OI) ₹30 Cr₹20 Cr₹20 Cr₹1,655,282 Cr₹17 Cr

What is the latest Operating Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Operating Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹30 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹30 Cr
Mar2024₹20 Cr
Mar2023₹20 Cr
Mar2022₹1,655,282 Cr
Mar2017₹17 Cr

How is Operating Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Operating Profit % Change
Mar2025 ₹30 Cr
48.98
Mar2024 ₹20 Cr
-0.67
Mar2023 ₹20 Cr
-100.00
Mar2022 ₹1,655,282 Cr
9,930,201.10
Mar2017 ₹17 Cr -

Compare Operating Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,310.4 Cr -0.4% -10.8% -27.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,299.0 Cr 0.5% 1.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹174,207.0 Cr -3.3% -3.5% 1.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,721.0 Cr 4.5% 2.6% 42.6% Stock Analytics
CIPLA ₹117,420.0 Cr 2.7% 2.5% -4% Stock Analytics
DR REDDYS LABORATORIES ₹114,876.0 Cr 6.6% 4.3% 1.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-0.4%

-10.8%

-27.5%

SENSEX

-0.1%

1%

-5.7%


You may also like the below Video Courses